....speculative Nasdaq biotech stocks in Phase I and II, which chances are will never pass Phase III as that is a 1 in 5,000 chance to pass Phase III and be a Phase IV like enzc and their ImuunH already incredibly is....
...IF so many of these Naz biotechs still trade .20 cents....to dollars to $30 or more a share w at times over $500 mil market caps....alllllll based on speculation.......what happens w proven Phase IV ENZC now that they are merging w fellow HIV and virus biotech cutting edge company BioClonetics that does this in age of Covid?:
“The Company also has created human cell lines that produce human antibodies against other infectious diseases, including rabies, influenza, tetanus and diphtheria. As a part of our mission, the Company is testing these antibodies to prepare them for use as therapies and vaccines against these diseases.“
Biotech speculation is like 95% of all unproven non-Phase IV biotech stocks on Naz.....yet market caps often in tens of millions to hundreds of millions. ....i think enzc has a long way to go...ie...NWBO has a $690 mil market cap...yet pages of debt and Warrants.....and has not passed Phase III yet onto Phase IV like enzc already has......and the MC w enzc today is ....drumroll ::: only $5 million........